Recent Articles By The Author
BioXcel Therapeutics and Albiero Pharma have promising prospects based on drugs in their pipelines.
La Jolla Pharmaceutical and Galera Therapeutics have nice upside potential.
I continue to be pessimistic about both growth in residential or commercial real estate value in major cities.
BeyondSpring Inc. and TG Therapeutics will be presenting at the American Society of Clinical Oncology's annual meeting.
Over the longer term I think a significant rise in inflation is inevitable and not factored in the market properly.
There's a merger involving one company, a collaborative agreement for another and hints of a positive regulatory development for a third.
M2 money supply has jumped nearly 25% over the past year, twice as much as during 1978 when inflation hit 13.4%.
Agenus Inc. and uniQure N.V. recently have announced positive news developments that should boost their long-term prospects.